eXCELL Biotherapeutics Inc.
Selected as a startup company by FINDIT Matchmaking in the past two years
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
eXCELL is an immunotherapy company that uses the body built-in immune rejection responses to non-self cells to combat the difficult-to-treat cancers by utilizing xenogeneic cells that could promote cancer immunity cycle due to the similarities between xen
Founded Year
2019
Unified Business No.
82820364
Status
Active
Number of Employees
6
Total Paid-in
Capital
47,533,330 (NT$)
Location of Company
Taiwan
, Taichung City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
To discover, develop, and diver transformative xenogeneic cellular medicines to cancer patients and improve their outcomes. eXCELL is a company dedicated to developing revolutionary therapies to meliorate people’s lives.
